IGF-1 LR3 claims on TikTok: what the science actually says

What did @6ixfoot7evenmogge actually say?

The creator described a pre-gym ritual of pre-filling syringes with IGF-1 LR3 and refrigerating them until post-workout. They specified using 30cc (likely 0.3mL insulin-style) needles because the compound "only comes in one-meg bottles" with doses in the one-to-three unit range. They also said they inject locally, referencing a belief that "you're supposed to do that with growth hormone," while admitting IGF-1 LR3 "might not have to" be injected locally. That last hedge is doing a lot of work here, because the local versus systemic injection debate around IGF-1 LR3 is genuinely unresolved, and conflating it with growth hormone protocols is where things start to slip.

The creator is self-experimenting with an unregulated research peptide, openly discussing dosing strategy and injection technique with 7,400 viewers, many of whom may take this as medical guidance. That context matters.

Does the science back this up?

Partially, and with serious caveats. IGF-1 LR3 is a synthetic analog of insulin-like growth factor 1, modified with an arginine substitution and a 13-amino-acid extension that reduces binding to IGF-binding proteins, extending its half-life to roughly 20-30 hours compared to native IGF-1's minutes (Baxter et al., 1992, European Journal of Endocrinology). That longer half-life is exactly why the local injection logic gets complicated.

The rationale for intramuscular local injection with IGF-1 comes from older bodybuilding culture, loosely based on research suggesting autocrine and paracrine IGF-1 signaling in skeletal muscle (Adams, 2002, Exercise and Sport Sciences Reviews). The idea is that injecting near the trained muscle targets hypertrophic signaling locally. However, because IGF-1 LR3 resists binding-protein clearance and circulates systemically for far longer than native IGF-1, the pharmacokinetic argument for local injection is significantly weaker. Your intramuscular dose goes systemic regardless. The creator's own uncertainty, "might not have to," reflects the actual state of the evidence.

Pre-filling syringes and refrigerating them is a practical question, not a pharmacological one, but peptide stability data is thin outside of pharmaceutical manufacturing conditions.

What did they get wrong (or right)?

They got the basic unit framing roughly right. IGF-1 LR3 is commonly supplied in 1mg vials reconstituted with bacteriostatic water, and dosing in "units" on an insulin syringe is standard practice in this community. On the needle description, though, there is a terminology error worth flagging. They said "30cc needles," but cc refers to volume, not gauge. They almost certainly mean 30-gauge needles, likely on a 0.3mL (30-unit) insulin syringe. That is a meaningful distinction for anyone trying to replicate this.

The local injection claim is where the video does the most damage. Framing intramuscular local injection as something "you're supposed to do" because of growth hormone protocols is inaccurate. Growth hormone is typically injected subcutaneously, not intramuscularly, and its mechanism of action is entirely different from IGF-1 LR3. Conflating the two protocols and presenting it as convention is misleading for a 7,400-person audience that may not know the difference.

Credit where it is due: the creator hedges. They say "apparently" and "might not have to," which is more epistemic honesty than most peptide content on TikTok. That does not make the framing safe, but it is worth noting.

What should you actually know?

IGF-1 LR3 is not approved by the FDA for human use. It is classified as a research chemical. That is not a technicality, it means there is no standardized human dosing, no long-term safety data in humans, and no regulatory oversight of the products being sold. Insulin-like growth factor signaling is also not something to tinker with casually. Dysregulated IGF-1 activity is associated with increased cancer cell proliferation across multiple tumor types (Pollak, 2008, Nature Reviews Cancer). That is not a reason to panic, but it is a reason to take seriously the fact that you are watching a TikTok, not consulting an endocrinologist.

The pre-filling and refrigeration approach raises legitimate sterility concerns. Reconstituted peptides are vulnerable to bacterial contamination if not handled under clean conditions, and there is no peer-reviewed guidance on how long a pre-filled syringe of IGF-1 LR3 remains stable or sterile in a home refrigerator.

If you are interested in peptide-based recovery or performance support, the appropriate path is a licensed telehealth provider who can review your bloodwork, discuss your goals, and prescribe within a legal and monitored framework, not a comment section.